Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

A | Agilent Technologies, Inc.

IndexS&P 500 P/E29.19 EPS (ttm)3.82 Insider Own0.30% Shs Outstand294.00M Perf Week-3.88%
Market Cap32.31B Forward P/E19.53 EPS next Y5.70 Insider Trans-0.51% Shs Float291.76M Perf Month-6.48%
Income1.13B PEG3.96 EPS next Q1.35 Inst Own90.70% Short Float / Ratio1.38% / 2.08 Perf Quarter-6.71%
Sales6.99B P/S4.62 EPS this Y6.10% Inst Trans-3.32% Short Interest4.04M Perf Half Y-15.04%
Book/sh18.90 P/B5.89 EPS next Y5.24% ROA10.60% Target Price139.81 Perf Year-11.91%
Cash/sh4.58 P/C24.31 EPS next 5Y7.37% ROE20.40% 52W Range109.00 - 160.26 Perf YTD-25.55%
Dividend0.90 P/FCF22.75 EPS past 5Y14.80% ROI16.90% 52W High-30.48% Beta1.04
Dividend %0.81% Quick Ratio1.70 Sales past 5Y8.90% Gross Margin50.90% 52W Low2.21% ATR2.97
Employees18300 Current Ratio2.30 Sales Q/Q-2.70% Oper. Margin20.20% RSI (14)35.53 Volatility1.97% 2.45%
OptionableYes Debt/Eq0.50 EPS Q/Q-65.80% Profit Margin16.20% Rel Volume1.05 Prev Close109.73
ShortableYes LT Debt/Eq0.49 EarningsAug 15 AMC Payout22.70% Avg Volume1.94M Price111.41
Recom2.30 SMA20-4.41% SMA50-7.91% SMA200-16.61% Volume2,050,534 Change1.53%
Date Action Analyst Rating Change Price Target Change
Jul-31-23Downgrade Evercore ISI Outperform → In-line $126 → $124
May-24-23Reiterated Wells Fargo Overweight $170 → $160
May-24-23Reiterated TD Cowen Outperform $168 → $145
May-24-23Reiterated SVB Securities Outperform $170 → $145
May-24-23Reiterated Stifel Hold $153 → $135
May-24-23Reiterated Robert W. Baird Outperform $174 → $144
May-24-23Reiterated Evercore ISI Outperform $150 → $126
May-24-23Reiterated Credit Suisse Outperform $170 → $160
May-24-23Reiterated Citigroup Neutral $150 → $130
May-24-23Reiterated BofA Securities Buy $164 → $144
Sep-20-23 03:06PM
01:13PM
10:15AM
Sep-18-23 09:00PM
01:03PM
01:11PM Loading…
Sep-15-23 01:11PM
Sep-14-23 11:30AM
Sep-12-23 08:35AM
Sep-05-23 10:36AM
07:45AM
07:40AM
07:35AM
07:20AM
05:34AM
Sep-01-23 08:34AM
08:00AM Loading…
Aug-24-23 08:00AM
Aug-21-23 04:26PM
10:49AM
Aug-17-23 11:38AM
Aug-16-23 05:07PM
01:48PM
12:59PM
12:37PM
07:55AM
Aug-15-23 08:04PM
06:31PM
06:27PM
06:00PM
04:15PM
04:05PM
02:00PM Loading…
Aug-13-23 02:00PM
Aug-11-23 11:56AM
Aug-09-23 06:15PM
08:00AM
Aug-03-23 08:00AM
07:25AM
Aug-02-23 03:32PM
Jul-31-23 04:26PM
09:00AM
Jul-26-23 06:15PM
Jul-19-23 12:00PM
Jul-10-23 10:52AM
08:01AM
Jul-06-23 06:15PM
Jul-05-23 08:09AM
Jul-03-23 01:29PM
08:00AM
Jun-29-23 06:15PM
Jun-23-23 06:15PM
Jun-22-23 11:30AM
08:00AM
Jun-14-23 11:54AM
Jun-13-23 12:02PM
Jun-12-23 08:00AM
Jun-08-23 08:00AM
08:00AM
May-26-23 03:56PM
May-24-23 04:16PM
04:11PM
04:00PM
01:17PM
01:01PM
12:55PM
12:55PM
11:15AM
10:34AM
09:00AM
06:56AM
04:07AM
May-23-23 07:48PM
05:25PM
04:05PM
03:38PM
May-22-23 06:00PM
May-21-23 03:00PM
May-19-23 11:08AM
08:46AM
08:30AM
May-18-23 09:25PM
12:14PM
09:39AM
08:32AM
07:24AM
May-17-23 03:57PM
07:16AM
May-16-23 06:00PM
02:47PM
11:52AM
11:35AM
10:00AM
09:00AM
08:25AM
07:22AM
May-15-23 01:17PM
12:58PM
12:34PM
08:52AM
07:24AM
May-12-23 02:05PM
02:04PM
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gonsalves RodneyV.P., Corporate ControllerAug 23Sale118.783,500415,71624,219Aug 25 12:53 PM
McMullen Michael R.CEO and PresidentJul 27Option Exercise42.1294439,761261,813Jul 31 03:03 PM
McMullen Michael R.CEO and PresidentJul 27Sale130.00944122,720260,869Jul 31 03:03 PM
Ancher-Jensen HenrikSr Vice PresidentDec 14Sale155.7829,5004,595,51070,793Dec 15 12:22 PM
Grau DominiqueSenior Vice PresidentDec 13Sale159.204,000636,80092,379Dec 15 12:20 PM
MCDONNELL PADRAIGSr. Vice PresidentDec 13Sale160.00672107,52015,529Dec 15 12:21 PM
KOH BOON HWEEDirectorDec 06Sale152.2113,0001,978,69257,752Dec 08 11:31 AM
Thaysen JacobSr. Vice PresidentDec 01Sale155.653,235503,52884,464Dec 02 01:45 PM
Thaysen JacobSr. Vice PresidentNov 30Sale154.639,7001,499,91287,699Dec 02 01:45 PM
Gonsalves RodneyV.P., Corporate ControllerNov 23Sale156.204,634723,83128,447Nov 28 03:47 PM
FIELDS HEIDIDirectorNov 23Sale155.843,635566,48254,484Nov 28 03:47 PM
McMullen Michael R.CEO and PresidentNov 22Option Exercise40.80128,7265,252,021389,417Nov 23 01:53 PM
McMullen Michael R.CEO and PresidentNov 22Sale155.73128,72620,046,500260,691Nov 23 01:53 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 22Sale153.907,5451,161,17646,499Nov 23 01:54 PM
MCDONNELL PADRAIGSr. Vice PresidentNov 22Sale153.212,746420,71516,201Nov 23 01:51 PM
McMullen Michael R.CEO and PresidentNov 16Option Exercise40.806,775276,420277,671Nov 18 03:03 PM
McMullen Michael R.CEO and PresidentNov 16Sale148.196,7751,003,987270,896Nov 18 03:03 PM
McMullen Michael R.CEO and PresidentNov 09Option Exercise40.806,775276,420198,133Nov 10 03:41 PM
McMullen Michael R.CEO and PresidentNov 09Sale138.316,775937,050191,358Nov 10 03:41 PM
McMullen Michael R.CEO and PresidentNov 02Option Exercise40.806,775276,420198,133Nov 04 10:54 AM
McMullen Michael R.CEO and PresidentNov 02Sale140.616,775952,633191,358Nov 04 10:54 AM
Tang MichaelSVP, General Counsel, and Sec.Nov 01Sale139.503,600502,20043,280Nov 03 09:52 AM
McMullen Michael R.CEO and PresidentOct 26Option Exercise40.806,775276,420198,133Oct 27 04:28 PM
McMullen Michael R.CEO and PresidentOct 26Sale134.436,775910,763191,358Oct 27 04:28 PM
McMullen Michael R.CEO and PresidentOct 19Option Exercise40.806,775276,420198,133Oct 21 05:01 PM
McMullen Michael R.CEO and PresidentOct 19Sale130.116,775881,495191,358Oct 21 05:01 PM
MCDONNELL PADRAIGSr. Vice PresidentSep 28Sale122.892,103258,43813,217Sep 30 10:34 AM